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Abstract
As the mortality from critical illness has improved in recent years,
there has been increasing focus on patient outcomes after hospital
discharge. Neuromuscular weakness acquired in the intensive care
unit (ICU) is common, persistent, and often severe. Immobility due
to prolonged bed rest in the ICU may play an important role in the
development of ICU-acquired weakness. Studies in other patient
populations have demonstrated that moderate exercise is bene-
ficial in altering the inflammatory milieu associated with immobility,
and in improving muscle strength and physical function. Recent
studies have demonstrated that early mobility in the ICU is safe and
feasible, with a potential reduction in short-term physical impair-
ment. However, early mobility requires a significant change in ICU
practice, with reductions in heavy sedation and bed rest. Further
research is required to determine whether early mobility in the ICU
can improve patients’ short-term and long-term outcomes.
Introduction
Bed rest has been prescribed for a wide range of conditions,
from acute medical illnesses to postoperative convalescence.
In intensive care units (ICUs) bed rest is especially common
[1,2]. However, a meta-analysis of 39 randomized trials
examining the effect of bed rest on 15 different medical
conditions and procedures demonstrated that bed rest was
not beneficial and may be associated with harm [3].
Immobility from prolonged bed rest is associated with many
complications, including muscle atrophy, pressure ulcers,
atelectasis, and bone demineralization [4].
With improving short-term survival among critically ill patients
[5], there is a growing appreciation of the neuromuscular
sequelae experienced by patients after hospital discharge. In
some ICU survivors, weakness can persist for years after
hospital discharge [6,7]. Although the etiology of this
weakness is multifactorial, early mobilization of ICU patients
may help to reduce the muscle atrophy, weakness, and
deconditioning associated with bed rest. Exercise is effective
in decreasing inflammation and all-cause mortality in healthy
individuals and patients with chronic disease [8,9]. This
review outlines the etiology and potential mechanisms of ICU-
acquired weakness. Furthermore, we highlight the potential
risks, benefits, and challenges of early mobility in the critically
ill to reduce ICU-acquired weakness and improve patient
outcomes.
Risk factors for critical illness associated
neuromuscular abnormalities
The etiology of ICU-acquired weakness is multifactorial, with
a number of studies establishing independent risk factors for
its development. Overall, disease severity (for instance, Acute
Physiology and Chronic Health Evaluation II score), the
presence of the systemic inflammatory response syndrome,
and organ failure are associated with neuromuscular abnor-
malities on electromyography/nerve conduction studies [10,11].
Moreover, the presence of clinically detectable muscle weak-
ness was positively associated with the number of days with
two or more organ dysfunctions in a multivariate analysis [12].
Other risk factors include the duration of mechanical
ventilation [12] and ICU length of stay [13], as well as serum
glucose levels [13], hyperosmolality [11], and use of paren-
teral nutrition [11]. Use of potentially myotoxic or neurotoxic
medications, such as corticosteroids [12] and nondepolarizing
neuromuscular blocking agents [11], has been associated
with neuromuscular abnormalities, although these findings
have not consistently been reported in other studies [10].
Immobility and muscle loss
The mechanisms by which critical illness leads to muscle
weakness are complex and involve several inter-related
processes (Figure 1). Pathophysiologically important mecha-
nisms for weakness include immobility, as well as local and
systemic inflammation, which act synergistically to promote
significant muscle loss in the critically ill patient. Importantly,
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prolonged bed rest associated with critical illness leads to
decreased muscle protein synthesis, increased urinary
nitrogen excretion (indicating muscle catabolism), and
decreased muscle mass, especially in the lower extremities
[14]. These changes lead to deleterious effects on muscle
weakness, with 1% to 1.5% of quadriceps muscle strength
lost for each day of bed rest in healthy individuals [15,16].
Both preclinical and clinical studies suggest a more profound
effect of immobilization in the elderly, with a greater loss of
lean body mass [14,17]. Additionally, the interaction of bed
rest and critical illness appears to result in more significant
muscle loss than bed rest alone [18-21].
Disuse atrophy is associated with specific structural and
metabolic changes in muscle. Specifically, animal studies
have demonstrated that proteolysis occurs during immobility
through three major pathways: calcium-dependent calpains
[22], lysosomal cathepsins [23], and the ubiquitin-protea-
some system [24]. Further muscle loss is mediated through
decreased protein synthesis by inhibition of initiation factors
by inhibitory 4E-BP-1 mRNA [25,26]. Modulation of these
pathways during immobility leads to a net loss in muscle
mass and cross-sectional muscle area, reduced contractile
strength, and a general shift from slow twitch (type I) to fast
twitch (type II) muscle fibers [26-29].
In addition to its direct effects on muscle, immobility can lead
to a pro-inflammatory state caused by increased systemic
inflammation via increases in pro-inflammatory cytokines
[30,31]. Long-term immobility may result in increased levels
of IL-1β, which plays an important role in muscle loss in other
conditions, such as the cachexia associated with chronic
obstructive pulmonary disease [32,33]. Levels of IL-2 and
interferon-γ pro-inflammatory cytokines are also elevated after
prolonged bed rest [33]. This cytokine shift may potentiate
the systemic inflammatory milieu that is commonly observed
during critical illness, leading to further muscle damage and
loss [34]. However, the exact role that that cytokines play in
muscle loss during immobilization must still be more fully
elucidated.
The pro-inflammatory state associated with bed rest also may
cause increased production of reactive oxygen species
(ROS), with a concomitant decrease in anti-oxidative defenses
[35,36]. ROS may play a role in tumor necrosis factor (TNF)-α
induced oxidization of myofilaments, resulting in contractile
dysfunction and atrophy [37-39]. Additionally, ROS may
trigger activation of both nuclear factor-κB and FOXO
signaling pathways, resulting in protein loss, possibly through
the ubiquitin-proteasome pathway [40]. This increase in ROS
and imbalance in the cytokine profile can further disrupt the
balance between muscle synthesis and proteolysis, with a net
loss of muscle protein and subsequent muscle weakness
[38,39].
In addition to immobility, critically ill patients commonly
experience protein-energy malnutrition, both before hospitali-
zation and during their ICU stay. Up to 40% of all hospitalized
Figure 1
Mechanisms and outcomes of neuromuscular weakness in critical illness. ICU, intensive care unit; ROS, reactive oxygen species.patients may be undernourished at the time of admission
[41]. Moreover critically ill patients commonly receive less
than 60% of their goal nutritional intake during their ICU stay,
thus further compounding this malnutrition [42,43]. Protein-
energy malnutrition, combined with the hypermetabolic
stresses of critical illness, results in significant protein loss in
the form of amino acids derived primarily from muscle [44].
Impact of immobility
Long-term immobility is associated multiple clinical complica-
tions (Table 1), having detrimental effects on patients during
and after their ICU stay. After 7 days of mechanical ventila-
tion, 25% to 33% of patients experience clinically evident
neuromuscular weakness, with severity of illness and duration
of ICU stay being important risk factors [12,10]. Patients with
ICU-acquired weakness have an increased duration of
mechanical ventilation and length of stay [45].
When evaluating ICU patients’ muscle function using
electromyography and nerve conduction studies, critical
illness-associated neuromuscular abnormalities are even
more common. A systematic review [46] demonstrated that
46% of the 1,421 ICU patients evaluated in 24 studies had
critical illness-associated neuromuscular abnormalities. These
abnormalities were associated with an increase in duration of
mechanical ventilation and length of stay. During follow up
after hospital discharge, more than 50% of patients develop-
ing critical illness-associated neuromuscular abnormalities
had persistent neuromuscular abnormalities [47], with 28%
suffering from severe disability such as tetraparesis, tetra-
plegia, or paraplegia [48].
During 1 year of follow up, one study of acute respiratory
distress syndrome [49] reported poor physical function and
decreased exercise tolerance in all survivors. These impair-
ments were attributed to the loss of muscle bulk, proximal
muscle weakness, and fatigue [49]. For years after hospital
discharge, physical aspects of quality of life are frequently
impaired (compared with age-matched and sex-matched
norms) in survivors of critical illness [50,51].
Prevention and treatment
At present, there are few options for the prevention and/or
treatment of ICU-acquired weakness [46,52,53]. In the ICU,
hyperglycemia [54,55] and certain medications (for example,
corticosteroids [12] and neuromuscular blocking agents
[56]) may be associated with the development of clinical
weakness and/or critical illness-associated neuromuscular
abnormalities. Strict glycemic control using intensive insulin
therapy may decrease neuromuscular abnormalities in patients
mechanically ventilated for 7 or more days [52,54,55].
Currently, controversies exist over the risks and benefits of
tight glycemic control in critically ill patients. In addition, a
causal relationship between the use of certain medications
and increased rates of neuromuscular abnormalities has not
been clearly established. Specifically, no studies have
demonstrated that avoidance of either corticosteroids or
nondepolarizing neuromuscular blocking agent results in
reduced incidence of neuromuscular abnormalities.
Beneficial effects of exercise
A potential therapeutic option to reduce ICU-acquired weak-
ness is avoidance of bed rest via early mobilization in the ICU
setting. In addition to improved strength, exercise may
decrease oxidative stress and inflammation [57,58]. During
moderate to strenuous exercise (60% to 75% of maximal
oxygen intake) in unfatigued skeletal muscle, small increases
in ROS activated cell-signaling pathways (for example, the
nuclear factor-κB pathway) are responsible for increased
protection against oxidative stress, by increased production
of antioxidants such as mitochondrial superoxide dismutase,
glutathione peroxidase, and γ-glutamylcysteine [57,59,60]. In
addition, moderate exercise leads to a shift toward increased
production of anti-inflammatory cytokines [9]. Typically, IL-6
(which has anti-inflammatory properties) is the first cytokine
to rise during exercise, increasing up to 100-fold greater than
pre-exercise levels, and then declines shortly after discon-
tinuation of exercise (<30 minutes) [61,62]. Furthermore,
both the IL-1 receptor antagonist and soluble TNF-α recep-
tor, inhibitors of pro-inflammatory cytokines, are also elevated
during exercise, without concomitant increases in the pro-
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Table 1
Selected adverse effects of prolonged bed rest
Musculoskeletal
￿ Decreased muscle protein synthesis [14]
￿ Muscle atrophy and decrease in lean muscle mass  [80] 
￿ Decreased muscle strength [14]
￿ Decreased exercise capacity [81]
￿ Connective tissue shortening and joint contractures [82]
￿ Decreased bone density [80]
￿ Pressure ulcers [83]
Pulmonary
￿ Atelectasis [84]
￿ Pneumonia [85]
￿ Decreased maximal inspiratory pressure and forced vital capacity [81]
Cardiovascular
￿ Decreased total cardiac and left ventricular size [86]
￿ Decreased lower extremity venous compliance [87]
￿ Orthostatic intolerance [88]
￿ Decreased cardiac output, stroke volume, and peripheral vascular 
resistance [86,89,90]
￿ Impaired microvascular function [91]
￿ Decreased cardiac response to carotid sinus stimulation [89]
Endocrine and Metabolism
￿ Decreased insulin sensitivity [91]
￿ Decreased aldosterone and plasma renin activity [92] 
￿ Increased atrial natriuretic peptide [93]inflammatory cytokines TNF-α and IL-1β [9,62]. Taken
together, antioxidant formation and a shift toward anti-inflam-
matory cytokines during moderate exercise may play an
important role in muscle preservation and protection.
Physical therapy in the intensive care unit
Physical therapy practices vary greatly across ICUs, ranging
from passive range of motion to transferring patients from the
bed to a chair. In general, more intensive physical therapy (for
example, ambulation) seldom occurs in mechanically venti-
lated patients [2,63]. A recent multisite study [43] demon-
strated that only 27% of patients with acute lung injury
received any physical therapy in the ICU, with treatments
occurring during only 6% of ICU days. Another observational
study of 20 physiologically stable patients with an ICU stay of
5 to 15 days [64] demonstrated that therapeutic activity
beyond simple turning and range of motion exercises was
rare, with only 1.5% of observed activities involving more
intensive therapy such as sitting in a chair or standing. One
study of patients mechanically ventilated via tracheostomy
[65] demonstrated that only 63% of patients sat out of bed,
with a median of two occasions per patient during the entire
ICU stay.
Safety concerns
There are unique challenges and safety concerns when
considering early mobilization of critically ill patients in the
ICU. However, existing data demonstrate that mobilization,
including ambulation, of mechanically ventilated patients can
be safe. In a study of 31 ICU patients who received a total of
69 mobilization treatments [66], a change in clinical status
occurred in only three (4%) of sessions. All three events
involved a transient decrease in oxygen saturation that
responded to an increase in supplemental oxygen. Moreover,
in a study of 103 ICU patients involving 1,449 activity events,
ranging from sitting in bed to ambulation, there were only 14
(<1%) minor adverse events in nine patients, with none
involving extubation or other unanticipated events requiring
additional therapy, cost, or duration of stay in hospital [67]. In
a controlled trial of a dedicated ICU mobility team [63] there
were no adverse events, despite patients in the mobility
protocol group receiving significantly more physical therapy
sessions. Guidelines currently exist regarding physical
therapy in the critically ill [68-70] that are based on expert
opinion, experience, and existing studies. These studies
illustrate that critically ill patients can be safely mobilized.
Culture change and feasibility of early
mobility in the intensive care unit
Barriers to early mobilization of ICU patients are multifactorial
and include lack of prioritization, long-established assump-
tions regarding the need for bed rest during critical illness,
and standing orders for activity restriction in the ICU [2,71].
These barriers illustrate the importance of ICU culture to
successful early mobilization of patients [72]. In one study of
mechanically ventilated patients undergoing an intra-hospital
transfer from a traditional ICU to an ICU in which early
mobilization was a priority [73], patients were 2.5 times more
likely to be ambulated after transfer. This increase in ambu-
lation could not be accounted for by differences in severity of
disease or underlying pathology, suggesting that many ICU
patients have an unmet potential for physical therapy and are
subjected to ‘unnecessary immobilization’ [68,73]. This
discrepancy between actual activity and patients’ potential for
activity poses an important target for improving rehabilitation
in the ICU. Indeed, the need for early activity in critically ill
patients was recently reinforced by European guidelines for
physiotherapy in the ICU [68].
A multidisciplinary focus on early mobilization is necessary as
part of daily clinical routines in the ICU. Early mobilization
begins immediately after physiologic stabilization. The defini-
tion of ‘physiologic stabilization’ varies among published
studies, but it usually takes into account neurologic, respira-
tory, and cardiovascular stability [63,66,67,69].
In addition to physiologic stability, clinicians may believe
mobilization is not feasible because of the presence of an
endotracheal tube, vascular access device, or other medical
equipment. However, in one prospective cohort study [67]
patients with an endotracheal tube participated in 593 activity
events ranging from sitting on the edge of the bed to ambu-
lation. Despite 42% of these events involving ambulation,
there were no accidental extubations [67]. Moreover, during a
total of 1,449 activity events, there was only one incident of
equipment dislodgment, which involved the accidental
removal of a feeding tube [67]. These results are further
reinforced by a controlled trial of a mobility protocol on 145
intubated ICU patients [63], in which no incidents of
accidental removal of devices were reported. These studies
indicate that early mobility in the ICU is feasible in ICUs with a
supportive culture.
Clinical outcomes after early mobility
Recent studies have demonstrated improved clinical out-
comes with early mobility in the ICU. A prospective cohort
study of 103 mechanically ventilated patients [67] demon-
strated that an early mobility program led to 69% of patients
ambulating more than 100 feet before ICU discharge.
Additionally, in another study of 104 ICU patients [73] an
early activity protocol resulted in 91 (88%) of patients ambu-
lating a median of 200 feet at ICU discharge. Although there
was no control group in these studies, this activity level is far
greater than existing reports of usual care in traditional ICUs
[63], in which ambulation therapy is frequently delayed until
after ICU discharge [74].
Recently, a controlled trial of mechanically ventilated medical
ICU patients [63] evaluated the benefits of an early mobility
protocol that provided rehabilitation therapy 7 days per week
via a dedicated mobility team. Through use of a mobility team
(consisting of a nurse, nurse assistant, and physical therapist)
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received physical therapy during their ICU stay (73% in the
protocol versus 6% in the usual care group), with a trend
toward decreased hospital mortality (12.1% versus 18.2%;
P = 0.125). After adjusting for differences in body mass
index, Acute Physiology and Chronic Health Evaluation II
score, and vasopressor use between the protocol and usual
care groups, early mobilization was associated with
decreased lengths of stay in the ICU (5.5 days versus
6.9 days; P = 0.025) and hospital (11.2 days versus 14.5 days;
P = 0.006) among survivors, and a trend toward decreased
duration of mechanical ventilation (8.8 days versus 10.2 days;
P = 0.163). Despite addition of the dedicated mobility team,
there was no difference in average hospital costs per patient
($41,142 versus $44,302 for protocol versus usual care
group; P = 0.262) [63].
Thus, early mobilization of critically ill patients may improve
physical function and shorten length of stay. However, the
results of these studies require further confirmation with
randomized controlled trials.
Other important changes to facilitate early
mobilization
Despite safety, feasibility, and potential short-term benefits,
barriers to early mobility remain because of established
approaches to sedation, incomplete knowledge, and lack of
resources in some ICUs [69]. Critically ill patients frequently
receive heavy sedation, especially when they are mechani-
cally ventilated [75]. Continuous sedative infusions are widely
used [76] and associated with increased duration of
mechanical ventilation [77]. Heavy sedation prevents patients
from participating in mobility activities. Daily interruption of
sedation infusions can result in decreased duration of
mechanical ventilation (4.9 days versus 7.9 days; P = 0.004)
and ICU length of stay (6.4 days versus 9.9 days; P = 0.02)
[78]. Use of lighter sedation also is potentially associated
with decreased long-term psychologic disturbances such as
post-traumatic stress [79]. Combined early mobility and
decreased sedation may have synergistic benefits.
Given many competing illnesses and treatments accom-
panying critical illness, early mobility often fails to be a high
priority in daily ICU patient care. Transforming ICU culture
requires prioritizing physical therapy. Culture change may be
assisted by clinician education regarding the significant and
persistent morbidity that occurs after critical illness, as well as
the safety, feasibility, and potential benefits of early mobility.
Targets for ICU culture change include institutional leader-
ship to support early mobility, as well as bedside clinicians
(for example, physicians, nurses, and physical therapists),
who play a crucial role in changing routine care [72].
The ICU environment may be unfamiliar to some physical
medicine and rehabilitation staff, just as rehabilitation therapy
may be unfamiliar to ICU staff. Familiarity with ICU equipment,
including cardiac monitors and ventilators, can help
rehabilitation staff to feel more comfortable in mobilizing
critically ill patients. Moreover, interdisciplinary education,
involving specialists from critical care, physical therapy,
occupational therapy, and nursing, will help to address these
knowledge gaps.
Specific resources can assist with a successful early mobility
program in the ICU. Adequate staffing from physical medicine
and rehabilitation clinicians is key. Such clinicians may
include physical and occupational therapists and a rehabili-
tation physician. A general neurologist or neuromuscular
subspecialist may also provide insights into investigation of
neuromuscular weakness. An overall leader for an early
mobility program can help to establish the necessary
coordination and cooperation among the multidisciplinary
team. However, with teamwork, training, and restructuring, it
may be possible to provide a higher level of physical activity
in the ICU without requiring additional resources [72].
Future directions
Our current understanding of the pathophysiology of ICU-
acquired weakness and the potential role of early mobility in
the ICU, including its safety, feasibility, and clinical benefit, is
at a relatively early stage. Future studies are needed to
elucidate the multiple mechanisms by which immobility and
other aspects of critical illness lead to muscle dysfunction
and loss. Although emerging data have demonstrated the
safety, feasibility, and potential benefit of early mobility in
critically ill patients, multicenter randomized, controlled trials
are needed to evaluate the potential short-term and long-term
benefits for patients’ muscle strength, physical function, and
quality of life. Future studies in critically ill patients with
primary trauma, surgical, and neurologic issues will comple-
ment the existing research that has focused predominantly on
ICU patients with medical conditions. In addition, important
differences in clinical practice between North America and
Europe, especially in the use of physiotherapists in the ICU,
may introduce variations in care that limit generalizability. A
study focused on studying such geographic differences in
practice would permit better comparison. Finally, other
interventions, such as neuromuscular electrical stimulation,
cycle ergometry, and optimization of nutrition, warrant
additional future investigation [69].
Conclusions
As the survival of critically ill patients continues to improve,
there is growing awareness of the significant long-term
neuromuscular complications that may occur after intensive
care. Bed rest in the ICU should not be viewed as benign and
may affect patients’ short-term and long-term recovery.
Immobility in the ICU contributes to neuromuscular sequelae
through several mechanisms, including a shift in cytokines,
increased inflammation, and disuse atrophy of skeletal
muscle. Interventions to prevent or treat ICU-acquired
weakness are few. Early mobility can be a safe and feasible
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ongoing preclinical and clinical research into the
mechanisms, prevention, and treatment of ICU-acquired
weakness, we can improve physical function and quality of
life for ICU survivors.
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